Through Global Patient Dialogues, we will implement a global, trusted patient-engagement series where patients’ experience, perspectives, needs and priorities are captured and disseminated so that they can be meaningfully incorporated into the medicines’ development lifecycle and patient care pathway.
Each Global Patient Dialogue features patients’ journey challenges and solutions for a disease. Through Global Patient Dialogues, patients’ experience, perspectives, needs, and priorities are captured and disseminated so that they can be meaningfully incorporated into the medicines development lifecycle as well as strategies to optimize the patient care pathway within health systems. These meetings enable innovators, researchers, and other key stakeholders, such as regulators, health system leaders, policymakers, and payers, to benefit from an impactful and memorable dialogue with patients and their care partners in specific, selected disease areas.
Industry innovators and researchers from pharmaceutical and device companies
Innovators and researchers in the public and private sectors
Health care system leaders
Regulators
Policymakers
Patient organization leaders
Community leaders
Health Care Providers
Payers
There will be a short pre- and post-survey for all registrants. All Patient3i deliverables will be posted on the site for all participants. Registrants will be directed to a webpage where they will be able to provide key questions of interest that they suggest be included in the dialogue discussion. Participants can submit questions to be posed by the moderator to patients. Registrants will receive a final agenda and objectives in advance of the Global Patient Dialogue.
A meeting confirmation, with date and place with a short pre-meeting survey
Objectives and agenda will be sent in advance of the Global Patient Dialogue to all registrants
Registrants will receive a Global Patient Dialogue Report in a timely and secure manner following the patient dialogue
Note: Participants can submit questions to be posed by the moderator to patients during the live patient dialogue.
health effects and daily impacts that matter most to patients
patient perspectives on current approaches to treatment and prevention
patient perspectives throughout their care pathway based on their health care system experience
The Global Patient Dialogue Report will include organized Patient Perspectives (US and EU) with the following major subject headings:
“One of the 21st Century pioneers of patient engagement practice in the Life Science Industry, Patient 3i leadership has done much to shape the environmental context and establish best practice in an actionable, impactful and sustainable way.”
"Bridging the chasm between patients’ needs and priorities and healthcare delivery is essential to ensuring effective, affordable products and services. Listening to and understanding patients’ experiences and challenges is the engine for developing new, viable healthcare solutions."
"Patient partnership in drug development is an absolute necessity, but the time and space necessary for meaningful collaboration is not a luxury many patients or other stakeholders have. Patient3i provides the forum for patient-centered, multi-stakeholder collaboration in the development of life-saving and quality of life-preserving therapies."
"Our ideals change as we expand our experiences. Our world becomes larger and more fascinating, and we find the courage to act on those new ideals. This is what Patient 3i will do for innovation!"
"Global Patient Dialogues creates a convenient, compliant listening forum for global innovators and patient communities to learn from each other directly!"
“Researchers and Innovators in Health Care will embrace a coordinated, efficient and trusted model driven by Patient Organization leadership, which defines relevant value for patients, informed by the latest regulatory guidance and patient engagement standards.”